Back to results
US 2019/0094229 A1Published application
Methods of diagnosing, classifying and treating endometrial cancer and precancer
AssigneesThe Translational Genomics Research Institute, Washington University
InventorsPamela Pollock, Paul Goodfellow
Life of this patent
Estimating the term…
Abstract
Diagnostic and therapeutic applications for endometrial cancer are described. The diagnostic and therapeutic applications are based on certain activation mutations in the FGFR2 gene and its expression products. The present invention is directed to nucleotide sequences, amino acid sequences, probes, and primers related to FGFR2 activation mutants and kits comprising these mutants to diagnosis and classify endometrial cancer in a subject.
Claims9
A method of classifying endometrial cancer, the method comprising:
- screening for a FGFR2 mutation in an endometrial cancer cell and classifying the type of endometrial cancer as a FGFR2 activation induced endometrial cancer upon finding a FGFR2 activation mutation in the endometrial cancer cell.
Dependencies are inferred from the claim text.